Skip to content

A comparative study between Clonidine and Buprenorphine as adjuvants Ropivacaine in Ultrasound guided Infraclavicular Brachial Plexus Block

A comparative study between Clonidine and Buprenorphine as adjuvants to 0.5 percent Ropivacaine in Ultrasound guided Infraclavicular Brachial Plexus Block - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070502
Enrollment
72
Registered
2024-07-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: T07- Unspecified multiple injuries

Interventions

Intervention1: INFRACLAVICULAR BRACHIAL PLEXUS BLOCK: Regional anaesthesia is comparatively safer and does not involve the potential side effects and complications that may arise from sedation and gen

Sponsors

vydehi institute of medical sciences and research centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex, aged 21-60 years, undergoing elective upper limb surgeries. 2. Patients belonging to American Society of Anesthesiologist (ASA) physical status I, II. 3. Patients within the weight range of 50-80kgs and within normal BMI.

Exclusion criteria

Exclusion criteria: 1. Patient refusal for the study. 2. Patients with coagulopathy or on anticoagulants. 3. Patients with pre-existing neuropathy involving brachial plexus. 4. Patients who have undergone prior surgeries of the infraclavicular fossa. 5. Patients with localized skin infections at site of block. 6. Patients with hypersensitivity to local anaesthetic

Design outcomes

Primary

MeasureTime frame
1.To evaluate and compare the onset for sensory blockade. 2.To evaluate and compare the onset for motor blockade. 3.To evaluate and compare the duration of sensory blockade. 4.To evaluate and compare the duration of motor blockade. Timepoint: 5 mins 10 mins 15 mins 20 mins 25 mins 30 mins 1 hour 2 hours 3 hours 6 hours 12 hours 24 hours

Secondary

MeasureTime frame
1. To assess hemodynamic variables. 2. To identify adverse effects to the drugs. Timepoint: hemodynamic variables are monitored in patients who receive the block for a duration of 24 hours & the at an interval sterting with 0min, 15min, 30min, 45min, 1hr, 2hrs, 3hrs, 6hrs, 12hrs & 24hrs Adverse effects are noted upto a duration of 24hours if any

Countries

India

Contacts

Public ContactDr. Pramathesh A

Department of Anaesthesiology

shishirsmashes@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026